DIMENSIONAL FUND ADVISORS LP

Holdings History for Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE)

Symbol: GLUE on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$8,913,806	568,367	-63,815	-10%	$15.68	Q4 2025
30 Sep 2025	0%	+0%	$4,683,844	632,182	+184,020	+41%	$7.41	Q3 2025
30 Jun 2025	0%	+0%	$2,021,329	448,162	+185,172	+70%	$4.51	Q2 2025
31 Mar 2025	0%	+0%	$1,220,273	262,990	+118,179		$4.64	Q1 2025
31 Dec 2024	0%	+0%	$1,004,988	144,811	+5,538	+4%	$6.94	Q4 2024
30 Sep 2024	0%	-0%	$738,147	139,273	-14,485	-9.4%	$5.30	Q3 2024
30 Jun 2024	0%	+0%	$575,055	153,758	+81,083	+112%	$3.74	Q2 2024
31 Mar 2024	0%	+0%	$512,359	72,675	+48,362	+199%	$7.05	Q1 2024
31 Dec 2023	0%	-0%	$137,368	24,313	-12,971	-35%	$5.65	Q4 2023
30 Sep 2023	0%	0%	$178,590	37,284	+16	+0.04%	$4.79	Q3 2023
30 Jun 2023	0%	0%	$255,286	37,268	0		$6.85	Q2 2023
31 Mar 2023	0%	+0%	$290,318	37,268	+37,268	NEW	$7.79	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.